Table of Contents

company-logo

CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC; CEL-2000 and CEL-4000 are product candidates for the treatment of rheumatoid arthritis; and LEAPS COV-19, a product candidate to treat COVID-19 coronavirus. CEL-SCI Corporation has a collaboration agreement with the University of Georgia's Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.

CEL-SCI Dividend Announcement

• CEL-SCI announced a annually dividend of $0.25 per ordinary share which will be made payable on . Ex dividend date: 1996-08-28
• CEL-SCI's trailing twelve-month (TTM) dividend yield is -%

CEL-SCI Dividend History

Ex-Div dateDividend amountDividend typePay date
1996-08-28$0.25annually

CEL-SCI Dividend per year

CEL-SCI Dividend Yield

CEL-SCI current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing CEL-SCI stock? Use our calculator to estimate your expected dividend yield:

CEL-SCI Financial Ratios

P/E ratio-1.37
PEG ratio1.33
P/B ratio4.59
ROE-233.88%
Payout ratio0.00%
Current ratio0.64
Quick ratio0.18
Cash Ratio0.07

CEL-SCI Dividend FAQ

Does CEL-SCI stock pay dividends?
CEL-SCI does not currently pay dividends to its shareholders.
Has CEL-SCI ever paid a dividend?
No, CEL-SCI has no a history of paying dividends to its shareholders. CEL-SCI is not known for its dividend payments.
Why doesn't CEL-SCI pay dividends?
There are several potential reasons why CEL-SCI would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will CEL-SCI ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While CEL-SCI has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is CEL-SCI a dividend aristocrat?
CEL-SCI is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is CEL-SCI a dividend king?
CEL-SCI is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is CEL-SCI a dividend stock?
No, CEL-SCI is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy CEL-SCI stocks?
To buy CEL-SCI you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy CEL-SCI stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.